Josh Resnick’s Gilead Sciences GILD Stock Holding History

Josh Resnick’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-29,000	Closed	-$2.17M	–	53
2020 Q1	$2.17M	Buy	+29,000	New	+$2M	0.17%	26

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Josh Resnick's GILD Position: Q2 2020 in Review

Josh Resnick sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 29,000 shares — an estimated $2.17M sold.

Josh Resnick first reported a position in GILD in Q1 2020 and held it in 1 quarter. The position peaked at $2.17M in Q1 2020. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Josh Resnick reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
Josh Resnick sold 29,000 Gilead Sciences shares in Q2 2020, an estimated $2.17M.
Josh Resnick first reported a position in Gilead Sciences in Q1 2020 and held it in 1 quarter.
Josh Resnick's Gilead Sciences position peaked at $2.17M in Q1 2020.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Jericho Capital Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.